Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin‐naïve people with Type 2 diabetes: the DUAL IV trial

AIM: To investigate the safety and efficacy of insulin degludec/liraglutide (IDegLira), a novel combination product, as add‐on therapy for people with Type 2 diabetes uncontrolled on sulphonylurea therapy. METHODS: In this 26‐week, double‐blind trial, adults with Type 2 diabetes [HbA(1c) 53–75 mmol/...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabet Med
Hlavní autoři: Rodbard, H. W., Bode, B. W., Harris, S. B., Rose, L., Lehmann, L., Jarlov, H., Thurman, J.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5811787/
https://ncbi.nlm.nih.gov/pubmed/27589252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dme.13256
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky